Ingenza Stock
Industrial biotechnology company
Sign up today and learn more about Ingenza Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Ingenza Stock
Ingenza was founded in 2002, a spin-out company from the University of Edinburgh that was based on the modification and commercialisation of microbial production technologies aimed at improving yields of unnatural amino acids and amines. Since its inception, Ingenza has remained strongly committed to the continuous development and integration of innovative technologies in its core competencies of molecular biology, gene expression, directed evolution, fermentation and process development. Ingenza is a world leader in the application of industrial biotechnology and synthetic biology, providing efficient, scalable bioprocesses for the manufacture of chemicals, biologics, pharmaceuticals and biofuels, from sustainable sources.
Funding History
August 2016 | $50K |
---|
Management
Managing Director
Ian Fotheringham
Co-Founder and Chief Executive Officer
Sinil Srivastava
COO
Jaymin Amin
Press
news-medical - Nov, 25 2023
Ingenza and Phibro Ethanol accelerate the green fuel transitionpharmiweb - Oct, 31 2023
Ingenza’s inGenius™ CMC platform paves the way for biotherapeutic successmarketscreener - Aug, 18 2023
Neurocrine Biosciences' Ingrezza Gets FDA Approvalseekingalpha - Jul, 7 2023
BMO upgrades Neurocrine to market perform on Ingrezza outlooknews-medical - Apr, 4 2023
Ingenza appoints Steve Jones as its new Chief Financial Officer